4.6 Article

Interactions of PARP1 Inhibitors with PARP1-Nucleosome Complexes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Inhibitors of PARP: Number crunching and structure gazing

Johannes Rudolph et al.

Summary: Selective inhibitors of PARP1 and PARP2 are used for treating cancer patients with DNA repair deficiencies. Talazoparib shows higher potency compared to other inhibitors due to its extensive interactions with conserved residues in the active site. The recently characterized protein HPF1 may play a role in designing the next generation PARP1/2 inhibitors.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Multidisciplinary Sciences

A two-step mechanism governing PARP1-DNA retention by PARP inhibitors

Huijun Xue et al.

Summary: PARP inhibitors modulate the retention of PARP1 on DNA lesions through a two-step mechanism, involving competitive inhibition of NAD(+) binding and allosteric modulation. The retention potency of PARPi is predominantly determined by its ability to outcompete NAD(+) binding.

SCIENCE ADVANCES (2022)

Review Biochemistry & Molecular Biology

PARP-1-Associated Pathological Processes: Inhibition by Natural Polyphenols

Natalya V. Maluchenko et al.

Summary: PARP-1 plays crucial roles in cell cycle regulation, DNA repair, transcription, and replication, with its hyperactivity promoting chronic pathological processes and moderate activation supporting tumor cell survival. Therefore, PARP inhibitors are considered promising agents for the treatment of tumors and metabolic diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Mechanisms of Nucleosome Reorganization by PARP1

Natalya V. Maluchenko et al.

Summary: The mechanisms of PARP1-nucleosome interaction are still unknown, with potential for PARP1-induced nucleosome reorganization to form an alternative state likely involved in gene regulation and DNA repair.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs

Johannes Rudolph et al.

Summary: PARP1 and PARP2 are key enzymes in the DNA damage response. HPF1 plays an essential role in modulating the PARylation of histones by forming a complex with both PARP1 and PARP2. Results show how HPF1 can affect the binding affinity of certain inhibitors to PARP1.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

The contribution of PARP1, PARP2 and poly(ADP-ribosyl)ation to base excision repair in the nucleosomal context

M. M. Kutuzov et al.

Summary: The study revealed that the presence of PARP1 leads to the suppression of BER enzymes' activities, while PARP2 predominantly influences the last stage of BER. PARylation attenuates the inhibitory effect of PARP1, but results in Pol beta inhibition and significant stimulation of LigIII alpha by PARP2 in a NAD(+)-dependent manner.

SCIENTIFIC REPORTS (2021)

Article Biology

Dual function of HPF1 in the modulation of PARP1 and PARP2 activities

Tatyana A. Kurgina et al.

Summary: The histone PARylation factor 1 (HPF1) has been found to stimulate the autoPARylation of PARP1 and PARP2 as well as the heteroPARylation of histones in the complex with nucleosome. The stimulatory action is dependent on the concentrations of HPF1 and NAD(+), with PARP2 showing more efficiency than PARP1 in the reaction. The dual function of HPF1 in maintaining PARP activity is also discussed.

COMMUNICATIONS BIOLOGY (2021)

Review Genetics & Heredity

The PARP Way to Epigenetic Changes

Simone Ummarino et al.

Summary: ADP-ribosylation is a reversible post-translational modification that modulates essential cellular processes through PARylation catalyzed by specialized enzyme poly ADP-ribose polymerases (PARP). PARP1 plays important roles in chromatin remodeling and epigenetic regulation, with therapeutic implications for cancer treatment and beyond.
Review Biochemistry & Molecular Biology

Poly(ADP-Ribosyl) Code Functions

N. Maluchenko et al.

Summary: Poly(ADP-ribosyl)ation plays a crucial role in cellular metabolism and various cellular processes through complex regulatory mechanisms. Pharmacological correction of PAR levels may provide a novel approach for treating a variety of diseases.

ACTA NATURAE (2021)

Review Biochemistry & Molecular Biology

Poly(ADP-ribose) polymerase enzymes and the maintenance of genome integrity

Travis Eisemann et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2020)

Article Biochemistry & Molecular Biology

Modeling of the Enzyme-Substrate Complexes of Human Poly(ADP-Ribose) Polymerase 1

D. K. Nilov et al.

BIOCHEMISTRY-MOSCOW (2020)

Editorial Material Cell Biology

PARPs and ADP-ribosylation: 60 years on

W. Lee Kraus

GENES & DEVELOPMENT (2020)

Article Biochemistry & Molecular Biology

Probing the Conformational Changes Associated with DNA Binding to PARP1

Johannes Rudolph et al.

BIOCHEMISTRY (2020)

Article Multidisciplinary Sciences

Structural basis for allosteric PARP-1 retention on DNA breaks

Levani Zandarashvili et al.

SCIENCE (2020)

Review Biotechnology & Applied Microbiology

Poly(ADP-ribose) polymerase inhibition: past, present and future

Nicola J. Curtin et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Article Biochemistry & Molecular Biology

A Single-Molecule Atomic Force Microscopy Study of PARP1 and PARP2 Recognition of Base Excision Repair DNA Intermediates

Maria V. Sukhanova et al.

JOURNAL OF MOLECULAR BIOLOGY (2019)

Review Oncology

A decade of clinical development of PARP inhibitors in perspective

J. Mateo et al.

ANNALS OF ONCOLOGY (2019)

Review Microbiology

Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity

Pamlea N. Brady et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2019)

Review Oncology

Synthetic lethal therapies for cancer: what's next after PARP inhibitors?

Alan Ashworth et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

PARP family enzymes: regulation and catalysis of the poly(ADP-ribose) posttranslational modification

Marie-France Langelier et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)

Article Multidisciplinary Sciences

High precision FRET studies reveal reversible transitions in nucleosomes between microseconds and minutes

Alexander Gansen et al.

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

Asymmetric unwrapping of nucleosomal DNA propagates asymmetric opening and dissociation of the histone core

Yujie Chen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Review Oncology

Targeting DNA repair and replication stress in the treatment of ovarian cancer

Junko Murai

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)

Review Cell Biology

PARP1 orchestrates epigenetic events setting up chromatin domains

Fabio Ciccarone et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)

Article Genetics & Heredity

Unfolding of core nucleosomes by PARP-1 revealed by spFRET microscopy

Daniel Sultanov et al.

AIMS GENETICS (2017)

Article Biochemistry & Molecular Biology

Large-scale ATP-independent nucleosome unfolding by a histone chaperone

Maria E. Valieva et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Large-scale ATP-independent nucleosome unfolding by a histone chaperone

Maria E. Valieva et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Kinase-Mediated Changes in Nucleosome Conformation Trigger Chromatin Decondensation via Poly(ADP-Ribosyl)ation

Colin J. Thomas et al.

MOLECULAR CELL (2014)

Article Multidisciplinary Sciences

Automodification switches PARP-1 function from chromatin architectural protein to histone chaperone

Uma M. Muthurajan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Biochemical Research Methods

Mapping PARP-1 Auto-ADP-ribosylation Sites by Liquid Chromatography-Tandem Mass Spectrometry

John D. Chapman et al.

JOURNAL OF PROTEOME RESEARCH (2013)

Review Oncology

Structural implications for selective targeting of PARPs

Jamin D. Steffen et al.

FRONTIERS IN ONCOLOGY (2013)

Article Oncology

Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors

Junko Murai et al.

CANCER RESEARCH (2012)

Article Biochemistry & Molecular Biology

The DNA-Binding Domain of Human PARP-1 Interacts with DNA Single-Strand Breaks as a Monomer through Its Second Zinc Finger

Sebastian Eustermann et al.

JOURNAL OF MOLECULAR BIOLOGY (2011)

Article Biochemistry & Molecular Biology

PARP1 ADP-ribosylates lysine residues of the core histone tails

Simon Messner et al.

NUCLEIC ACIDS RESEARCH (2010)